224 related articles for article (PubMed ID: 9699795)
1. Urinary and biliary excretion kinetics of 1-hydroxypyrene following intravenous and oral administration of pyrene in rats.
Bouchard M; Viau C
Toxicology; 1998 May; 127(1-3):69-84. PubMed ID: 9699795
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion kinetics of 1-hydroxypyrene following intravenous administration of binary and ternary mixtures of polycyclic aromatic hydrocarbons in rat.
Bouchard M; Krishnan K; Viau C
Arch Toxicol; 1998; 72(8):475-82. PubMed ID: 9765062
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the urinary excretion time courses of pyrene-1,6-dione, pyrene-1,8-dione and 1-hydroxypyrene in rats intravenously exposed to pyrene.
Ruzgyte A; Bouchard M; Viau C
Biomarkers; 2006; 11(5):417-27. PubMed ID: 16966159
[TBL] [Abstract][Full Text] [Related]
4. The toxicokinetics of pyrene and its metabolites in rats.
Viau C; Bouchard M; Carrier G; Brunet R; Krishnan K
Toxicol Lett; 1999 Sep; 108(2-3):201-7. PubMed ID: 10511263
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion kinetics of 1-hydroxypyrene in rats subchronically exposed to pyrene or polycyclic aromatic hydrocarbon mixtures.
Bouchard M; Thuot R; Carrier G; Viau C
J Toxicol Environ Health A; 2002 Aug; 65(16):1195-209. PubMed ID: 12167216
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of tissue distribution and elimination of pyrene and 1-hydroxypyrene following intravenous administration of [14C]pyrene in rats.
Bouchard M; Krishnan K; Viau C
Toxicol Sci; 1998 Nov; 46(1):11-20. PubMed ID: 9928664
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites.
Bouchard M; Viau C
Toxicol Appl Pharmacol; 1996 Aug; 139(2):301-9. PubMed ID: 8806846
[TBL] [Abstract][Full Text] [Related]
8. Dietary fibers reduce the urinary excretion of 1-hydroxypyrene following intravenous administration of pyrene.
Viau C; Zaoui C; Charbonneau S
Toxicol Sci; 2004 Mar; 78(1):15-9. PubMed ID: 14691205
[TBL] [Abstract][Full Text] [Related]
9. Urinary excretion kinetics of 1-hydroxypyrene in volunteers exposed to pyrene by the oral and dermal route.
Viau C; Carrier G; Vyskocil A; Dodd C
Sci Total Environ; 1995 Feb; 163(1-3):179-86. PubMed ID: 7716496
[TBL] [Abstract][Full Text] [Related]
10. Effect of polycyclic aromatic hydrocarbons on the elimination kinetics of pyrene and the urinary excretion profile of 1-hydroxypyrene in the rat.
Lipniak-Gawlik M
J Toxicol Environ Health A; 1998 Dec; 55(7):503-16. PubMed ID: 9860324
[TBL] [Abstract][Full Text] [Related]
11. Correlation between biomarkers of polycyclic aromatic hydrocarbon exposure and electrophilic tissue burden in a rat model.
Tzekova A; Thuot R; Viau C
Arch Toxicol; 2004 Jun; 78(6):351-61. PubMed ID: 14749914
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous analysis of naphthols, phenanthrols, and 1-hydroxypyrene in urine as biomarkers of polycyclic aromatic hydrocarbon exposure: intraindividual variance in the urinary metabolite excretion profiles caused by intervention with beta-naphthoflavone induction in the rat.
Elovaara E; Väänänen V; Mikkola J
Arch Toxicol; 2003 Apr; 77(4):183-93. PubMed ID: 12698233
[TBL] [Abstract][Full Text] [Related]
13. Simulation of urinary excretion of 1-hydroxypyrene in various scenarios of exposure to polycyclic aromatic hydrocarbons with a generic, cross-chemical predictive PBTK-model.
Jongeneelen F; ten Berge W
Int Arch Occup Environ Health; 2012 Aug; 85(6):689-702. PubMed ID: 22038087
[TBL] [Abstract][Full Text] [Related]
14. Amounts and proportion of administered pyrene dose excreted as urinary 1-hydroxypyrene after dietary exposure to polycyclic aromatic hydrocarbons.
Chien YC; Yeh CT
Arch Toxicol; 2010 Oct; 84(10):767-76. PubMed ID: 20571775
[TBL] [Abstract][Full Text] [Related]
15. Development of a high-performance liquid chromatographic method for the simultaneous determination of pyrene-1,6- and 1,8-dione in animal and human urine.
Ruzgyte A; Bouchard M; Viau C
J Anal Toxicol; 2005 Sep; 29(6):533-8. PubMed ID: 16168175
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration.
Bouchard M; Viau C
Can J Physiol Pharmacol; 1997 Mar; 75(3):185-92. PubMed ID: 9164700
[TBL] [Abstract][Full Text] [Related]
17. Urinary 1-hydroxypyrene as a biomarker of exposure to polycyclic aromatic hydrocarbons: biological monitoring strategies and methodology for determining biological exposure indices for various work environments.
Viau MB
Biomarkers; 1999; 4(3):159-87. PubMed ID: 23885861
[TBL] [Abstract][Full Text] [Related]
18. In vivo formation of mutagens by intraperitoneal administration of polycyclic aromatic hydrocarbons in animals during exposure to nitrogen dioxide.
Miyanishi K; Kinouchi T; Kataoka K; Kanoh T; Ohnishi Y
Carcinogenesis; 1996 Jul; 17(7):1483-90. PubMed ID: 8706253
[TBL] [Abstract][Full Text] [Related]
19. Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption.
Kang DH; Rothman N; Poirier MC; Greenberg A; Hsu CH; Schwartz BS; Baser ME; Groopman JD; Weston A; Strickland PT
Carcinogenesis; 1995 May; 16(5):1079-85. PubMed ID: 7767968
[TBL] [Abstract][Full Text] [Related]
20. Airborne exposure to polycyclic aromatic hydrocarbons (PAHs) and urinary excretion of 1-hydroxypyrene of carbon anode plant workers.
Petry T; Schmid P; Schlatter C
Ann Occup Hyg; 1996 Jun; 40(3):345-57. PubMed ID: 8694494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
